AARD · Categories · Form 4
AARD - SEC Form 4 insider transactions
Aardvark Therapeutics Inc. (AARD) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for AARD
- SEC Form 4 filed by Chief Financial Officer Sun Nelson4 - Aardvark Therapeutics, Inc. (0001774857) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Lee Tien-Li4 - Aardvark Therapeutics, Inc. (0001774857) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Jaiman Manasi4 - Aardvark Therapeutics, Inc. (0001774857) (Issuer)
- Chief Executive Officer Lee Tien-Li exercised 1,229 shares at a strike of $4.24, increasing direct ownership by 0.08% to 1,544,613 units (SEC Form 4)4 - Aardvark Therapeutics, Inc. (0001774857) (Issuer)
- Chief Operating Officer Jones Bryan exercised 1,250 shares at a strike of $4.24 (SEC Form 4)4 - Aardvark Therapeutics, Inc. (0001774857) (Issuer)
- Chief Executive Officer Lee Tien-Li exercised 17,209 shares at a strike of $4.24, increasing direct ownership by 1% to 1,513,384 units (SEC Form 4)4 - Aardvark Therapeutics, Inc. (0001774857) (Issuer)
- SEC Form 4 filed by Director Chi Jeffrey4 - Aardvark Therapeutics, Inc. (0001774857) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Lee Tien-Li4 - Aardvark Therapeutics, Inc. (0001774857) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Sun Nelson4 - Aardvark Therapeutics, Inc. (0001774857) (Issuer)
- SEC Form 4 filed by Director Tong Victor Edward Jr4 - Aardvark Therapeutics, Inc. (0001774857) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Jaiman Manasi4 - Aardvark Therapeutics, Inc. (0001774857) (Issuer)
- SEC Form 4 filed by Director Baynes Roy D.4 - Aardvark Therapeutics, Inc. (0001774857) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Jones Bryan4 - Aardvark Therapeutics, Inc. (0001774857) (Issuer)
- SEC Form 4 filed by Director Graf Susan E4 - Aardvark Therapeutics, Inc. (0001774857) (Issuer)
- Director Chi Jeffrey converted options into 133,364 shares (SEC Form 4)4 - Aardvark Therapeutics, Inc. (0001774857) (Issuer)
- Large owner Vickers Venture Fund Vi Pte Ltd converted options into 2,050,902 shares (SEC Form 4)4 - Aardvark Therapeutics, Inc. (0001774857) (Issuer)